Including acquisition costs and other charges, Life Technologies said it earned 22 cents per share in the most recent quarter. During the period it also agreed to sell its interest in Applied Biosystems/MDS Sciex, a mass spectrometry business, to Danaher Corp. Life Technologies now forecasts a profit of $2.90 to $2.95 per share, up from between $2.70 and $2.80 per share. That includes a "modest" benefit from stimulus funds. Analysts were expecting $2.80 per share. In morning trading, its stock rose $2.21, or 4.7 percent, to $49.26. They reached a high of $49.94.